| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 172,955 | 169,063 | 118,947 | 148,989 | | Cost of Revenue | 114,513 | 114,492 | 95,649 | 103,950 | | | Gross Profit | 58,442 | 54,571 | 23,298 | 45,039 | | | Operating Expenses | | Research Development | 28,282 | 27,467 | 23,222 | 24,634 | | Selling General and Administrative | 19,408 | 19,851 | 16,808 | 17,426 | | Non Recurring | (8) | 2,954 | 4 | 33,875 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,738 | 4,299 | (16,736) | (30,896) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 182 | 214 | 644 | (2,004) | | Earnings Before Interest And Taxes | 10,942 | 4,513 | (16,092) | (32,900) | | Interest Expense | 179 | 224 | 318 | 400 | | Income Before Tax | 10,763 | 4,289 | (16,410) | (33,300) | | Income Tax Expense | 254 | 386 | (766) | 1,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,509 | 3,903 | (15,644) | (34,300) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,509 | 3,903 | (15,644) | (34,300) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,509 | $3,903 | ($15,644) | ($34,300) |
|
0.20% Nasdaq 
0.14%
Income Statement
